2009 Biopharma Deals Of The Year: Roche/Genentech, Movetis' IPO, Elan/J&J
Which pharmaceutical and biotech deal-making and financing developments of the past year are the most surprising, creative or precedent-setting
Which pharmaceutical and biotech deal-making and financing developments of the past year are the most surprising, creative or precedent-setting